Solventum Corp (SOLV) Stock
NYSE · SOLV
88.84
Fundamentals
Market cap
$15.12B
Price / Earnings ratio
10.4x
Price / Sales ratio
1.8x
Price / Book ratio
3.1x
Return on assets
0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Solventum Corp
Solventum is a global healthcare solutions company that develops, manufactures, and commercializes a range of products for the medical, dental, and health information industries, leveraging material science, data science, and digital capabilities
SectorHealthcare
IndustryHealth Information Services
Employees20,584
CEOMr. Bryan C. Hanson
IPO DateMar 26, 2024
HeadquartersEagan, MN
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Bryan C. Hanson | CEO & Director | 1967 |
| Mr. Wayde D. McMillan | Executive VP & CFO | 1970 |
| Ms. Amy Landucci | Chief Information & Digital Officer | 1975 |
| Ms. Marcela A. Kirberger | Chief Corporate & Legal Affairs Officer & Corporate Secretary | 1967 |
| Ms. Heather L. Knight | Chief Commercial Officer | 1972 |
| Mr. Neil C. Zieselman | Senior VP, Controller & Chief Accounting Officer | 1976 |
| Ms. Amy Wakeham | Senior Vice President of Investor Relations & External Finance Communications | — |
| Ms. Kate Dobbs | Chief Communications & Corporate Marketing Officer | — |
| Ms. Rachel H. Ellingson | Chief Strategy & Corporate Development Officer | 1970 |
| Ms. Tammy L. Gomez | Chief Human Resources Officer | 1973 |
Fundamentals
Valuation
Market cap$15.12B
Price-to-sales ratio1.79
Price-to-book value3.10
Price-earnings ratio10.40
Return on Equity31.00%
Return on Sales0.24%
Return on Assets0.10%
PEG ratio1.22
Earnings Per Share
Earnings Per Share$8.22
Income Statement
Average volume905,093
EBITDA$2.49B
1 year high (52w)$94.16
1 year low (52w)$62.38
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



